PSYB Stock Overview
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
PsyBio Therapeutics Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.01 |
52 Week High | CA$0.07 |
52 Week Low | CA$0.005 |
Beta | 0.65 |
1 Month Change | 0% |
3 Month Change | 33.33% |
1 Year Change | -80.00% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -98.36% |
Recent News & Updates
Shareholder Returns
PSYB | CA Biotechs | CA Market | |
---|---|---|---|
7D | 0% | -1.8% | 0.2% |
1Y | -80.0% | -28.6% | 9.0% |
Return vs Industry: PSYB underperformed the Canadian Biotechs industry which returned -24.5% over the past year.
Return vs Market: PSYB underperformed the Canadian Market which returned 2.6% over the past year.
Price Volatility
PSYB volatility | |
---|---|
PSYB Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 13.5% |
Market Average Movement | 8.6% |
10% most volatile stocks in CA Market | 18.5% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: PSYB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PSYB's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Evan Levine | https://www.psybiolife.com |
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company is headquartered in Denver, Colorado.
PsyBio Therapeutics Corp. Fundamentals Summary
PSYB fundamental statistics | |
---|---|
Market cap | CA$1.33m |
Earnings (TTM) | -CA$2.57m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.5x
P/E RatioIs PSYB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PSYB income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$50.00k |
Gross Profit | -US$50.00k |
Other Expenses | US$1.85m |
Earnings | -US$1.90m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.014 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did PSYB perform over the long term?
See historical performance and comparison